NURIX THERAPEUTICS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
NURIX THERAPEUTICS, INC. (NRIX) had Deferred Tax Liabilities, Property, Plant and Equipment of $8.00 thousand as of 2019-11-30, per its 10-K filed 2021-02-16.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2021-02-16
- 2019-11-30: Deferred Tax Liabilities, Property, Plant and Equipment $8.00K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2019-11-30 | $8.00K 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |